Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: A4HDB1
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006399 | tRNA metabolic process | 7 | 1 |
GO:0006400 | tRNA modification | 6 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008033 | tRNA processing | 8 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0030488 | tRNA methylation | 5 | 1 |
GO:0032259 | methylation | 2 | 1 |
GO:0034470 | ncRNA processing | 7 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0034660 | ncRNA metabolic process | 6 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043414 | macromolecule methylation | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0005488 | binding | 1 | 6 |
GO:0008168 | methyltransferase activity | 4 | 6 |
GO:0008171 | O-methyltransferase activity | 5 | 6 |
GO:0008173 | RNA methyltransferase activity | 4 | 6 |
GO:0008175 | tRNA methyltransferase activity | 5 | 6 |
GO:0016740 | transferase activity | 2 | 6 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 6 |
GO:0043167 | ion binding | 2 | 6 |
GO:0043169 | cation binding | 3 | 6 |
GO:0046872 | metal ion binding | 4 | 6 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 5 | 6 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 6 | 6 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 6 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 6 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 6 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 18 | 22 | PF00656 | 0.294 |
CLV_NRD_NRD_1 | 185 | 187 | PF00675 | 0.649 |
CLV_NRD_NRD_1 | 188 | 190 | PF00675 | 0.596 |
CLV_NRD_NRD_1 | 304 | 306 | PF00675 | 0.311 |
CLV_NRD_NRD_1 | 333 | 335 | PF00675 | 0.311 |
CLV_NRD_NRD_1 | 369 | 371 | PF00675 | 0.218 |
CLV_PCSK_FUR_1 | 186 | 190 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 185 | 187 | PF00082 | 0.581 |
CLV_PCSK_KEX2_1 | 188 | 190 | PF00082 | 0.503 |
CLV_PCSK_KEX2_1 | 304 | 306 | PF00082 | 0.311 |
CLV_PCSK_KEX2_1 | 333 | 335 | PF00082 | 0.311 |
CLV_PCSK_KEX2_1 | 369 | 371 | PF00082 | 0.218 |
CLV_PCSK_PC7_1 | 181 | 187 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 181 | 185 | PF00082 | 0.615 |
CLV_PCSK_SKI1_1 | 212 | 216 | PF00082 | 0.311 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.342 |
CLV_Separin_Metazoa | 227 | 231 | PF03568 | 0.511 |
DOC_CKS1_1 | 113 | 118 | PF01111 | 0.425 |
DOC_CKS1_1 | 382 | 387 | PF01111 | 0.511 |
DOC_CYCLIN_RxL_1 | 66 | 77 | PF00134 | 0.337 |
DOC_CYCLIN_RxL_1 | 93 | 104 | PF00134 | 0.303 |
DOC_MAPK_gen_1 | 369 | 375 | PF00069 | 0.446 |
DOC_MAPK_gen_1 | 98 | 105 | PF00069 | 0.304 |
DOC_PP1_RVXF_1 | 196 | 203 | PF00149 | 0.511 |
DOC_PP1_RVXF_1 | 67 | 74 | PF00149 | 0.338 |
DOC_PP2B_PxIxI_1 | 238 | 244 | PF00149 | 0.511 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.540 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.277 |
DOC_USP7_MATH_1 | 276 | 280 | PF00917 | 0.418 |
DOC_USP7_MATH_1 | 303 | 307 | PF00917 | 0.511 |
DOC_USP7_MATH_1 | 31 | 35 | PF00917 | 0.306 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.340 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.546 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.419 |
DOC_WW_Pin1_4 | 381 | 386 | PF00397 | 0.511 |
LIG_14-3-3_CanoR_1 | 135 | 144 | PF00244 | 0.376 |
LIG_14-3-3_CanoR_1 | 189 | 195 | PF00244 | 0.329 |
LIG_14-3-3_CanoR_1 | 201 | 207 | PF00244 | 0.425 |
LIG_14-3-3_CanoR_1 | 280 | 288 | PF00244 | 0.511 |
LIG_BIR_III_2 | 204 | 208 | PF00653 | 0.511 |
LIG_BRCT_BRCA1_1 | 33 | 37 | PF00533 | 0.330 |
LIG_deltaCOP1_diTrp_1 | 283 | 288 | PF00928 | 0.418 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.418 |
LIG_FHA_1 | 62 | 68 | PF00498 | 0.282 |
LIG_FHA_2 | 16 | 22 | PF00498 | 0.354 |
LIG_FHA_2 | 73 | 79 | PF00498 | 0.299 |
LIG_Integrin_isoDGR_2 | 127 | 129 | PF01839 | 0.368 |
LIG_LIR_Gen_1 | 104 | 113 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 255 | 263 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 347 | 358 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 104 | 108 | PF02991 | 0.327 |
LIG_LIR_Nem_3 | 122 | 126 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 196 | 200 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 255 | 260 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 347 | 353 | PF02991 | 0.511 |
LIG_MLH1_MIPbox_1 | 33 | 37 | PF16413 | 0.330 |
LIG_NRBOX | 66 | 72 | PF00104 | 0.284 |
LIG_Pex14_1 | 284 | 288 | PF04695 | 0.418 |
LIG_PTB_Apo_2 | 256 | 263 | PF02174 | 0.418 |
LIG_PTB_Phospho_1 | 256 | 262 | PF10480 | 0.418 |
LIG_SH2_CRK | 123 | 127 | PF00017 | 0.384 |
LIG_SH2_CRK | 257 | 261 | PF00017 | 0.418 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.286 |
LIG_SH2_STAP1 | 371 | 375 | PF00017 | 0.492 |
LIG_SH2_STAT3 | 262 | 265 | PF00017 | 0.511 |
LIG_SH2_STAT3 | 371 | 374 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 257 | 260 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.483 |
LIG_SH2_STAT5 | 378 | 381 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.288 |
LIG_SH3_2 | 207 | 212 | PF14604 | 0.511 |
LIG_SH3_3 | 110 | 116 | PF00018 | 0.437 |
LIG_SH3_3 | 153 | 159 | PF00018 | 0.456 |
LIG_SH3_3 | 204 | 210 | PF00018 | 0.511 |
LIG_SH3_3 | 240 | 246 | PF00018 | 0.511 |
LIG_SH3_3 | 379 | 385 | PF00018 | 0.511 |
LIG_SUMO_SIM_anti_2 | 60 | 69 | PF11976 | 0.299 |
LIG_TRFH_1 | 242 | 246 | PF08558 | 0.418 |
LIG_TYR_ITIM | 121 | 126 | PF00017 | 0.390 |
LIG_WRC_WIRS_1 | 102 | 107 | PF05994 | 0.327 |
LIG_WRC_WIRS_1 | 194 | 199 | PF05994 | 0.418 |
MOD_CDK_SPK_2 | 381 | 386 | PF00069 | 0.511 |
MOD_CDK_SPxxK_3 | 381 | 388 | PF00069 | 0.511 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.339 |
MOD_CK1_1 | 279 | 285 | PF00069 | 0.418 |
MOD_CK1_1 | 306 | 312 | PF00069 | 0.511 |
MOD_CK2_1 | 288 | 294 | PF00069 | 0.511 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.285 |
MOD_GlcNHglycan | 138 | 141 | PF01048 | 0.370 |
MOD_GlcNHglycan | 222 | 225 | PF01048 | 0.311 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.354 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.306 |
MOD_GlcNHglycan | 334 | 337 | PF01048 | 0.245 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.252 |
MOD_GSK3_1 | 173 | 180 | PF00069 | 0.512 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.511 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.459 |
MOD_GSK3_1 | 340 | 347 | PF00069 | 0.466 |
MOD_N-GLC_1 | 284 | 289 | PF02516 | 0.311 |
MOD_N-GLC_2 | 387 | 389 | PF02516 | 0.311 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.355 |
MOD_NEK2_1 | 220 | 225 | PF00069 | 0.588 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.418 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.457 |
MOD_NEK2_2 | 284 | 289 | PF00069 | 0.511 |
MOD_NEK2_2 | 31 | 36 | PF00069 | 0.317 |
MOD_NEK2_2 | 82 | 87 | PF00069 | 0.303 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.405 |
MOD_PIKK_1 | 107 | 113 | PF00454 | 0.361 |
MOD_PIKK_1 | 88 | 94 | PF00454 | 0.349 |
MOD_PKA_2 | 136 | 142 | PF00069 | 0.380 |
MOD_PKA_2 | 200 | 206 | PF00069 | 0.511 |
MOD_PKA_2 | 276 | 282 | PF00069 | 0.497 |
MOD_PKA_2 | 303 | 309 | PF00069 | 0.511 |
MOD_PKA_2 | 332 | 338 | PF00069 | 0.511 |
MOD_PKB_1 | 179 | 187 | PF00069 | 0.600 |
MOD_Plk_1 | 284 | 290 | PF00069 | 0.511 |
MOD_Plk_1 | 31 | 37 | PF00069 | 0.329 |
MOD_Plk_4 | 101 | 107 | PF00069 | 0.324 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.557 |
MOD_Plk_4 | 284 | 290 | PF00069 | 0.418 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.433 |
MOD_Plk_4 | 5 | 11 | PF00069 | 0.473 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.415 |
MOD_ProDKin_1 | 381 | 387 | PF00069 | 0.511 |
TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.390 |
TRG_ENDOCYTIC_2 | 257 | 260 | PF00928 | 0.418 |
TRG_ENDOCYTIC_2 | 360 | 363 | PF00928 | 0.511 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.294 |
TRG_ER_diArg_1 | 179 | 182 | PF00400 | 0.609 |
TRG_ER_diArg_1 | 185 | 188 | PF00400 | 0.520 |
TRG_ER_diArg_1 | 369 | 371 | PF00400 | 0.434 |
TRG_Pf-PMV_PEXEL_1 | 230 | 235 | PF00026 | 0.431 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IG18 | Leishmania donovani | 77% | 86% |
A4I0P4 | Leishmania infantum | 77% | 86% |
E9AWP4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 86% |
Q4QAS7 | Leishmania major | 77% | 86% |